% Encoding: UTF-8

@TechReport{Pfizer2021,
  author      = {Worldwide Safety Pfizer},
  title       = {5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report},
  institution = {Pfizer},
  year        = {2021},
  type        = {resreport},
  url         = {https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf},
}

@Article{GeorgeWilson1932,
  author   = {George Wilson and Samuel B. Hadden},
  title    = {Neuritis and Multiple Neuritis Following Serum Therapy},
  journal  = {JAMA},
  year     = {1932},
  volume   = {98},
  number   = {2},
  pages    = {123-125},
  month    = {January},
  issn     = {1538-3598},
  abstract = {With the increased use of therapeutic serums in the past twenty years, much has been written of the various manifestations of anaphylaxis. Urticaria, arthralgia, adenopathy and cardiac collapse are well known complications of serum therapy. Coma and occasionally death have been reported following serum injection. Many reports of multiple neuritis and myelitis following the use of Pasteur treatment have appeared, and encephalitis following vaccination is well known. Another unpleasant complication of prophylactic efforts, and fortunately one less frequently seen, is multiple neuritis.

In 1912, Thaon reported a case in which paralysis of the serratus magnus and other muscles developed following serum sickness due to the injection of 10 cc. of tetanus antitoxin. In 1915, Richardson reported a case of severe tetanus with recovery, which was followed by a pronounced multiple neuritis that he attributed to the action of the tetanus toxin. Dyke in 1918 wrote on neuritis...},
  comment  = {Also archived at https://archive.vn/Nw4nq},
  doi      = {10.1001/jama.1932.02730280031007},
  url      = {https://jamanetwork.com/journals/jama/article-abstract/1153665},
}

@Misc{SteveAnderson2020,
  author       = {Steve Anderson},
  title        = {October 22, 2020 Meeting Presentation},
  howpublished = {US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee},
  month        = {October},
  year         = {2020},
  comment      = {The listed URL is from the Internet Archive: Wayback Machine as the original document at the original URL is now gone.},
  url          = {https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download},
}

@Article{Iyengar194,
  author  = {K. G. Iyengar},
  title   = {Serum Shock and Serum Reaction},
  journal = {The Indian Medical Gazette},
  year    = {194},
  pages   = {249-250},
  month   = {May},
  url     = {https://web.archive.org/web/20200207182423/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC5158424&blobtype=pdf},
}

@Article{Yerushalmi2002,
  author  = {Joseph Yerushalmi, Alex Zvulunov, Sima Halevy},
  title   = {Serum Sickness-like Reactions},
  journal = {Cutis},
  year    = {2002},
  volume  = {69},
  pages   = {395-397},
  month   = {May},
  url     = {https://web.archive.org/web/20200321001112/http://www.gums.ac.ir/Upload/Modules/Contents/asset68/069050395.pdf},
}

@Article{Williams1952,
  author  = {D. A. Williams},
  title   = {Emergencies in General Practice; Serum and Anaphylactic Reactions},
  journal = {British Medical Journal},
  year    = {1952},
  volume  = {1},
  number  = {4928},
  pages   = {1469-1471},
  month   = {June},
  issn    = {0007-1447},
  comment = {Additional URL to Internet Archive:Wayback Machine PDF: https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf},
  url     = {https://www.bmj.com/content/1/4928/1469},
}

@Comment{jabref-meta: databaseType:bibtex;}
